{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT04825613",
      "OrgStudyIdInfo": {
        "OrgStudyId": "HBPLS01"
      },
      "Organization": {
        "OrgFullName": "Hope Biosciences",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "\"Individual Patient Expanded Access IND to Treat Primary Lateral Sclerosis",
      "OfficialTitle": "\"Individual Patient Expanded Access IND to Evaluate the Safety and Efficacy of HB-adMSCs for the Treatment of Primary Lateral Sclerosis\"",
      "Acronym": "HBPLS"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2021",
      "OverallStatus": "Temporarily not available",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StudyFirstSubmitDate": "March 25, 2021",
      "StudyFirstSubmitQCDate": "March 25, 2021",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "April 1, 2021",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "March 25, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "April 1, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Hope Biosciences Stem Cell Research Foundation",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Hope Biosciences",
            "CollaboratorClass": "INDUSTRY"
          }
        ]
      }
    },
    "OversightModule": {},
    "DescriptionModule": {
      "BriefSummary": "This Individual Patient Expanded Access IND has been created as requested by an 83-year-old man who suffers Primary Lateral Sclerosis and for which the drugs currently approved are not providing an improvement over the progression of this disease.",
      "DetailedDescription": "This is an Individual Patient Expanded Access IND with the primary goal of treatment for an individual with Primary Lateral Sclerosis. There are no FDA approved, fully restorative treatments for Primary Lateral Sclerosis. The subject will receive a total of twelve autologous monthly HB-adMSCs infusions of 200 million cells."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Primary Lateral Sclerosis, Adult, 1"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Expanded Access"
    },
    "ArmsInterventionsModule": {
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "HB-adMSCs",
            "InterventionDescription": "Hope Biosciences adipose derived Mesenchymal Stem Cells",
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "MSC's"
              ]
            }
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nAdult individual at least 18 years old\nClinical diagnosis Primary Lateral Sclerosis.\nSubject or Legal Authorized Representative has provided informed consent before initiation of any study procedure.\nSubject has mesenchymal stem cells banked at Hope Biosciences.\n\nExclusion Criteria:\n\nClinically significant, uncontrolled cardiovascular, lung, renal, hepatic, or endocrine disease or any other acute or chronic medical condition that, in the opinion of the principal investigator, may increase the risks associated with study participation.\nChemical or ETOH dependency that in the opinion of the investigator would preclude participation in the study.\nParticipation in concurrent interventional research studies during this expanded access.\nUnwillingness to return for follow-up visits.",
      "Gender": "Male",
      "MinimumAge": "18 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Hope Biosciences Stem Cell Research Foundation",
            "LocationCity": "Sugar Land",
            "LocationState": "Texas",
            "LocationZip": "77478",
            "LocationCountry": "United States"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 21, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000016472",
            "ConditionMeshTerm": "Motor Neuron Disease"
          },
          {
            "ConditionMeshId": "D000012598",
            "ConditionMeshTerm": "Sclerosis"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000019636",
            "ConditionAncestorTerm": "Neurodegenerative Diseases"
          },
          {
            "ConditionAncestorId": "D000009422",
            "ConditionAncestorTerm": "Nervous System Diseases"
          },
          {
            "ConditionAncestorId": "D000009468",
            "ConditionAncestorTerm": "Neuromuscular Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M14567",
            "ConditionBrowseLeafName": "Sclerosis",
            "ConditionBrowseLeafAsFound": "Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M18031",
            "ConditionBrowseLeafName": "Motor Neuron Disease",
            "ConditionBrowseLeafAsFound": "Primary Lateral Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M3176",
            "ConditionBrowseLeafName": "Amyotrophic Lateral Sclerosis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M20711",
            "ConditionBrowseLeafName": "Neurodegenerative Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11563",
            "ConditionBrowseLeafName": "Neuromuscular Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T4699",
            "ConditionBrowseLeafName": "Primary Lateral Sclerosis",
            "ConditionBrowseLeafAsFound": "Primary Lateral Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T349",
            "ConditionBrowseLeafName": "Amyotrophic Lateral Sclerosis",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC10",
            "ConditionBrowseBranchName": "Nervous System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC18",
            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    }
  }
}